• Hamid Javaid Qureshi
  • Ghulam Hussain
  • Zafar Altaf Jafary
  • Muhammad Usman Bashir
  • Naghmana Latif
  • Zeeshan Riaz


Background: In postmenopausal women, the two major causes of bone loss are oestrogendeficiency after menopause and age related processes. Bone turnover increases to high levels andoestrogen deficiency may induce calcium loss by indirect effects on extra skeletal calciumhomeostasis. Objective of this study was to evaluate calcium status in pre-menopausal andpostmenopausal women. Methods: This cross sectional study was carried out in 34premenopausal women and 33 postmenopausal women, in Department of Physiology, ServicesInstitute of Medical Sciences, Lahore. Height and weight of each woman were taken to find outthe body mass index (BMI). Serum calcium, parathyroid hormone and calcitonin levels of eachsubject were determined. Results: Premenopausal women were obese (BMI>30 Kg/m2) whilepostmenopausal women were overweight (BMI>25 Kg/m2). Serum calcium levels weresignificantly lower in postmenopausal women than in pre-menopausal women, while serumparathyroid hormone levels were significantly higher in postmenopausal woman. Serum calcitoninlevel was not significantly different in the two groups. Conclusion: Postmenopausal women arecalcium deficient and have increased bone turnover as indicated by increased serum parathyroidhormone levels.Keywords: Premenopausal, postmenopausal, calcium, parathyroid hormone, calcitonin.


Sheweita S, Khoshal K. Calcium metabolism and oxidative

stress in bone fractures: role of antioxidants. Curr Drug

Metab 2007;8:519–25.

Guyton AC, Hall JE. Parathyroid hormone, calcitonin,

calcium and phosphate metabolism, vitamin D, bone and

teeth. Text book of Medical Physiology 11th ed. Philadelphia:

Elsevier Saunders; 2006.pp.901,940,978–95.

Garneo P, Delmas PD. Bone turnover markers. In:

Encyclopedia of Endocrine Diseases. Eds Martin L.

California: Elsevier Inc; 2004.pp.401–13.

Riggs BL, Melton LJ. Medical progress series: involutional

osteoporosis. N Engl J Med 1986;314:1676–86.

Uebelhart D, Schlemmer A, Johansen JS, Gineyts E,

Christiansen C, Delmas PD. Effect of menopause and

hormone replacement therapy on the urinary excretion of

pyridinium cross-links. J Clin Endocrinal Metab


Gennari C, Agnusdei D, Nardi P, Citvitelli R. Estrogen

preserves a normal intestinal responsiveness to 1.25-

dihydroxy vitamin D3 in oophorectomized women. J Clin

Endocrinal Metab 1990;71:1288–93.

Nordin BC, Need AG, Morris HA, Oloughlin PD, Horowitz

M. Effect of age on calcium absorption in postmenopausal

women. Am J Clin Nut 2004;80:998–1002.

Nieves JW, Komar L, Cosman F, Lindsay R. Calcium

potentiates the effect of estrogen and calcitonin on bone mass:

review and analysis. Am J Clin Nutrit 1998;67:18–24.

World Health Organization. Factsheet No. 311 - Obesity and

Overweight. September 2006. Geneva. Available at:

Garton M, Martin J, New S, Lee S, Loveridge N, Milne J et

al. Bone mass and metabolism in women aged 45–55. Clin

Endocrinal (Oxf). 1996;44:563–73.

Eastell R, Yergey AL, Vieira N, Cedel SL. Kumar R. Riggs

BL. Interrelationship among vitamin D metabolism, true

calcium absorption, parathyroid function and age in women:

evidence of an age-related intestinal resistance to 1, 25 (OH)2

D action. J Bone Miner Res 1991;6:125–32.

Taboulet J, Frenkian M, Frendo JL, Feingold N, Jullienne A,

de Vernejoul MC. Calcitonin receptor polymorphism is

associated with a decreased fracture risk in postmenopausal

women. Human Mole Genet 1998;7;2129–33.

Khosla S, Elizabeth J, Atkinson L, Melton III J, Riggs BL.

Effects of age and estrogen status on serum parathyroid

hormone levels and biochemical markers of bone turnover in

women: A population based study. J Clin Endocrinal Metabol


Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effects

of calcium and vitamin D supplementation on bone density in

men and women 65 years of age or older. N Engl J Med